成人多发性肌炎/皮肌炎持续缓解的预测因素:按肌炎特异性自身抗体分层
该回顾性研究纳入162例随访超过1年的成人PM/DM患者,其中102例可全面评估MSA。中位随访4年时持续缓解率为58%。MSA阴性患者持续缓解率显著高于抗ARS、抗MDA5或抗TIF1-γ抗体阳性患者。多因素分析显示MSA阴性和诊断时无需要协助的严重肌无力是持续缓解的独立预测因素。
要点
- MSA阴性患者持续缓解率显著高于抗ARS、抗MDA5或抗TIF1-γ抗体阳性患者。
- MSA阴性和诊断时无严重肌无力是持续缓解的独立预测因素。
- 同时具备MSA阴性和无严重肌无力者累积缓解率显著更高。
核心结论
- MSA阴性状态和诊断时无需要协助的严重肌无力是成人PM/DM患者持续缓解的独立预测因素。
研究设计与样本
- 回顾性纳入162例随访超过1年的成人PM/DM患者,其中102例血清可及者全面评估MSA,查阅病历收集临床数据。
主要发现
- 全部患者中位随访4年时持续缓解率为58%。
- MSA阴性患者持续缓解率显著高于抗氨基酸-tRNA合成酶抗体阳性者(P=0.004)。
- MSA阴性患者持续缓解率显著高于抗MDA5抗体阳性者(P=0.037)。
- MSA阴性患者持续缓解率显著高于抗TIF1-γ抗体阳性者(P=0.013)。
- 多因素分析中MSA阴性(OR 5.84,P=0.009)和诊断时无需要协助的严重肌无力(OR 43.6,P<0.001)与持续缓解独立相关。
关键数值与推荐
- 持续缓解定义为在接受肌炎治疗或未用药状态下,连续超过6个月无疾病活动证据(无活动性皮疹、活动性肌炎或活动性间质性肺病)。
临床怎么用
- 对成人PM/DM患者可检测MSA并进行分层,MSA阴性且诊断时无严重肌无力者可能更易达到持续缓解。
局限性
- 原文未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to clarify predictive factors for sustained remission in adult patients with PM/DM, particularly focusing on stratification by myositis-specific autoantibodies (MSAs). METHODS: A total of 162 adult patients with PM/DM who were followed up for >1 year after diagnosis were retrospectively enrolled. MSAs were evaluated comprehensively in 102 patients whose sera were available. Sustained remission was defined as no evidence of disease activity (active skin rash, active myositis or active interstitial lung disease) for longer than a 6-month continuous period while undergoing myositis therapy or no medication. Clinical data were reviewed in patients' medical charts. RESULTS: The sustained remission rate for all patients was 58% during the median follow-up period at 4 years. With regard to MSAs, the achievement rate of sustained remission among MSA-negative patients was significantly higher than that for patients with anti-aminoacyl-tRNA synthetase (P = 0.004), anti-melanoma differentiation-associated gene 5 (P = 0.037) or anti-transcriptional intermediary factor 1-γ (P = 0.013) antibodies. MSA-negative status (odds ratio 5.84, P = 0.009) and absence of severe muscle weakness requiring assistance at diagnosis (odds ratio 43.6, P < 0.001) were independent factors associated with sustained remission in multivariate analysis. Cumulative remission rates were significantly higher (P < 0.001) in patients with both the MSA-negative status and absence of severe muscle weakness at diagnosis than the others. CONCLUSION: MSA-negative status and the absence of severe muscle weakness requiring assistance at diagnosis are independent predictive factors for sustained remission in adult PM/DM patients.
引用
- Watanabe E, Gono T, Kuwana M, et al. Predictive factors for sustained remission with stratification by myositis-specific autoantibodies in adult polymyositis/dermatomyositis. Rheumatology (Oxford). 2020. PMID: 31410476. doi:10.1093/rheumatology/kez328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。